Research and Markets: Pharmaceutical Industry in the Netherlands - Economic Trends, Competition, Key Players, SWOT Analysis of Leading Companies & Much More

DUBLIN--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/0865dc/pharmaceutical_ind) has
announced the addition of the "Pharmaceutical Industry in the Netherlands"
report to their offering.

The birth origins of the Pharmaceutical Industry can be traced back to more
humble antecedents than just chemistry labs. The earliest incidents of
recognition of the antiseptic properties of the dyestuffs is around the late
19th century. The invention of penicillin can yet be recognized as a major
milestone for the emergent industry which firmly consolidated its R&D efforts in
the 1950's. Further in the 1960's the patent regulation support gave a further
impetus to the industry in new discoveries and relaxed controls on clinical
development with the booming spend on healthcare as economies boomed globally.

The global presence of the pharmaceutical industry is evident with the roll out
of continent specific R&D programs and drugs which help companies maximize
penetration of markets and garner increased revenues with intercontinental
treatment demand of patients being serviced from often one or two mega research
centers in the continent.

The pharmaceutical industry is under mounting scrutiny because of rapidly
increasing expenditures for drugs worldwide. Drug expenditures are now the
fastest-growing component of health care costs, increasing at the rate of about
15 percent per year. They account for about eight percent of health care
spending, and at their current rate of increase, they will soon surpass spending
for physicians' services and, for many health care organizations, the costs of
hospitalization.

This report brings you a complete analysis of the Pharmaceutical Industry in The
Netherlands. The report covers a brief profile of the global pharmaceutical
industry, the TRIPS agreement, offshoring in the pharmaceutical industry,
economic trends in the industry, competition in the industry, and the key
players in the pharmaceutical industry in the Netherlands - complete with a SWOT
analysis of the leading companies in the market.

Key Topics Covered:

A. Executive Summary

B. The Global Pharmaceutical Industry - A Brief Profile B.1 Industry Definition
B.2 Industry Overview B.3 Industry Forecast

C. TRIPS and the Global Pharmaceutical Industry C.1 Introduction C.2 Product
Patents and Prices of Medicines C.3 Product Patents and Research and Development
C.4 Patents and Technology Transfer C.5 Flexibility in the Agreement

D. Pharmaceutical Industry in the Netherlands D.1 Industry Overview D.2 Industry
Value and Market Share D.3 Industry Segmentation D.4 Industry Forecast

E. Competition in the Industry

F. Leading Players in the Market F.1 AstraZeneca Plc F.2 GlaxoSmithKline Plc F.3
Pfizer Inc

G. Appendix G.1 Offshoring in the Pharmaceutical Sector G.2.1 Offshoring of R&D
G.3.1 Offshoring of Pharmaceutical Manufacturing Processes

H. Glossary of Terms

Companies Mentioned:

* AstraZeneca Plc
* Pfizer Inc.
* GlaxoSmithKline Plc

For more information visit
http://www.researchandmarkets.com/research/0865dc/pharmaceutical_ind

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Copyright Business Wire 2009